---
figid: PMC6325472__ajcr0008-2359-f1
figtitle: PI3K pathway activation and cell-cycle in tumor cells
organisms:
- Homo sapiens
pmcid: PMC6325472
filename: ajcr0008-2359-f1.jpg
figlink: /pmc/articles/PMC6325472/figure/fig01/
number: F1
caption: 'A. The Mechanistic relationship between PI3K pathway activation and cell-cycle
  in tumor cells: PI3K signaling engages AKT, which drives mTORC1 CAP-dependent mRNA
  translation encoding CYCLIN D1/D2/D3. CYCLIN D1/D2/D3 bind CDK4/6 to promote RB
  phosphorylation, which depresses E2F transcription factor to drive expression of
  genes that promote proliferation and suppress apoptosis. CDK6 can phosphorylate
  FOXOM1 to enhance FOXOM1 stability, which suppresses senescence. Blue: FDA approved
  drugs and RED: Active in a clinical trial. B. Intramolecular interactions between
  PIK3CA and PIK3R1: Domain-specific regulation of PIK3CA (a p110α catalytic subunit
  of PI3K) by PIK3R1 (p85α regulatory subunit of PI3K) as scaffolds for regulated
  complex formation. Distribution of some important non-synonymous mutations of PIK3CA
  and PIK3R1 were depicted.'
papertitle: 'A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor
  to combat endocrine resistance in hormone receptor-positive breast cancer: a genomic
  algorithm-based treatment approach.'
reftext: Anita Gul, et al. Am J Cancer Res. 2018;8(12):2359-2376.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8694331
figid_alias: PMC6325472__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6325472__F1
ndex: 1db95ce8-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6325472__ajcr0008-2359-f1.html
  '@type': Dataset
  description: 'A. The Mechanistic relationship between PI3K pathway activation and
    cell-cycle in tumor cells: PI3K signaling engages AKT, which drives mTORC1 CAP-dependent
    mRNA translation encoding CYCLIN D1/D2/D3. CYCLIN D1/D2/D3 bind CDK4/6 to promote
    RB phosphorylation, which depresses E2F transcription factor to drive expression
    of genes that promote proliferation and suppress apoptosis. CDK6 can phosphorylate
    FOXOM1 to enhance FOXOM1 stability, which suppresses senescence. Blue: FDA approved
    drugs and RED: Active in a clinical trial. B. Intramolecular interactions between
    PIK3CA and PIK3R1: Domain-specific regulation of PIK3CA (a p110α catalytic subunit
    of PI3K) by PIK3R1 (p85α regulatory subunit of PI3K) as scaffolds for regulated
    complex formation. Distribution of some important non-synonymous mutations of
    PIK3CA and PIK3R1 were depicted.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PTEN
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - GSK3B
  - RPTOR
  - CDK6
  - CDK4
  - RPS6KB1
  - EIF4EBP1
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - C2
  - CSH2
  - UBE2G1
  - Tamoxifen
  - AZD6482
  - AZD2014
  - AZD5363
  - Everolimus
  - M10431
---
